HALOZYME THERAPEUTICS, INC. (HALO) earnings date

Nasdaq · Large cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 36 days, typically, give or take 6 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Thu, Nov 5, 2026after close 36 8-K
Q2 FY2026Thu, Aug 6, 2026after close 37 8-K
Q1 FY2026Mon, May 11, 2026after close 41 8-K
Q4 FY2025Tue, Feb 17, 2026after close 48 8-K
Q3 FY2025Mon, Nov 3, 2025after close 34 8-K
Q2 FY2025Tue, Aug 5, 2025after close 36 8-K
Q1 FY2025Tue, May 6, 2025after close 36 8-K
Q4 FY2024Tue, Feb 18, 2025after close 49 8-K

What they guided beta

Q3 FY2026 "Document Exhibit 99.1 HALOZYME REPORTS THIRD QUARTER 2026 RESULTS AND RAISES FULL YEAR 2026 FINANCIAL GUIDANCE Total Revenue Increased 39% YOY to $493 million Royalty Revenue Increased 44% YOY to $341 million Raising 2026 Financial Guidance Ranges: Total Revenue of $1.860 - $1.925 billion, YOY Growth of 33% - 38% Royalty Revenue of $1.235 - $1.255 billion, YOY Growth of 42% - 45% Adjusted EBITDA of $1.240 - $1.290 billion, YOY Growth of 89% - 96% 1 Non-GAAP Diluted EPS of $8.75 - $9.05, YOY Growth of 111% - 118% 1 Expanded ENHANZE ® Collaboration Agreements with Three Current Partners Three E" exhibit
Q3 FY2026 "“Based on our strong financial performance this quarter, we are pleased to be able to raise our guidance for the full year 2026,” said Darren Snellgrove, Executive Vice President and Chief Financial Officer." exhibit
Q3 FY2026 "In September 2026, Halozyme and Incyte expanded their collaboration to evaluate the SC formulation of axatilimab, a monoclonal antibody targeting colony-simulating factor-1 receptor, with ENHANZE ® ." exhibit
Q3 FY2026 "Financial Outlook for 2026 The Company is raising its 2026 financial guidance ranges, which were last updated on August 6, 2026." exhibit
Q3 FY2026 "For the full year 2026, the Company expects:" exhibit
Q2 FY2026 "Document Exhibit 99.1 HALOZYME REPORTS RECORD SECOND QUARTER 2026 RESULTS, BEATS ESTIMATES AND RAISES FULL YEAR 2026 FINANCIAL GUIDANCE Total Revenue Increased 48% YOY to $481 million Royalty Revenue Increased 50% YOY to $308 million Raises 2026 Financial Guidance Ranges: Total Revenue of $1.835 - $1.910 billion, YOY Growth of 31% - 37% Royalty Revenue of $1.220 - $1.245 billion, YOY Growth of 41% - 43% Adjusted EBITDA of $1.225 - $1.280 billion, YOY Growth of 86% - 95% 1 Non-GAAP Diluted EPS of $8.65 - $9.00, YOY Growth of 108% - 117% 1 Signed Five New ENHANZE ® and Hypercon ™ Collaboration " exhibit
Q2 FY2026 "Based on these record results, we are raising our full year 2026 financial guidance.”" exhibit
Q2 FY2026 "Financial Outlook for 2026 The Company is raising its 2026 financial guidance ranges, which were last provided on May 11, 2026." exhibit
Q2 FY2026 "For the full year 2026, the Company expects:" exhibit
Q2 FY2026 "Table 1. 2026 Financial Guidance Previous Guidance Range New Guidance Range Total Revenue $1.710 to $1.810 billion $1.835 to $1.910 billion Royalty Revenue $1.130 to $1.170 billion $1.220 to $1.245 billion Adjusted EBITDA 1 $1.125 to $1.205 billion $1.225 to $1.280 billion Non-GAAP Diluted EPS 1 $7.75 to $8.25 $8.65 to $9.00 1 EBITDA, Adjusted EBITDA and Non-GAAP Diluted EPS are Non-GAAP financial measures." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/HALO
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/HALO

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

HALO earnings date badge

HTML

<a href="https://veritasdata.dev/company/HALO/"><img src="https://veritasdata.dev/embed/HALO.svg" alt="HALO earnings date" width="240" height="56"></a>

Markdown

[![HALO earnings date](https://veritasdata.dev/embed/HALO.svg)](https://veritasdata.dev/company/HALO/)

Script

<script async src="https://veritasdata.dev/embed/HALO.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/HALO"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.